Dr. Reddy's Laboratories Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Dr. Reddy's Laboratories (DRREDDY (BSE Code: 500124)) Key Ratios
Dr. Reddy's Laboratories Share Price Analysis API (Live)
Dr. Reddy's Laboratories share price is ₹1,171.00, day high (share price) is ₹1,179.90, day low (share price) is ₹1,166.50 and volume is 556,259. 52 Week high share price for Dr. Reddy's Laboratories is ₹1,414.90 on 29 Jun 2026 and 52 week low share price for Dr. Reddy's Laboratories is ₹1,101.00 on 23 Jul 2026. Price data as of: 01 Sep, 2026 3:31 PM.
According to latest price data (as of 01 Sep, 2026 3:31 PM) for Dr. Reddy's Laboratories share, 14 day period RSI (Relative Strength Index) is 44.4, 50 DMA (50 Displaced Moving Average) is 1,222.76 and 200 DMA (200 Displaced Moving Average) is 1,254.64.
Dr. Reddy's Laboratories (DRREDDY) Technical Analysis
Dr. Reddy's Laboratories Technical Data and Analysis available in multiple timeframes.
Dr. Reddy's Laboratories Oscillators Analysis
Dr. Reddy's Laboratories Price Action
Dr. Reddy's Laboratories Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 44.37 |
| Stoch %K (14, 3, 3) | 24.71 |
| CCI (20) | -61.16 |
| ADX (14) | 26.19 |
| Awesome Osc | 0.59 |
| Momentum (10) | -7.80 |
| MACD (12, 26, 9) | -9.72 |
| MACD Signal | -10.69 |
| Stoch RSI (14) | 29.20 |
| Williams %R (14) | -69.09 |
| Bull/Bear Power | -8.63 |
| Ultimate Osc | 49.49 |
| MFI (14) | 36.99 |
| ROC (21) | -0.76 |
| ROC (125) | -11.24 |
| ATR (14) | 22.29 |
Dr. Reddy's Laboratories Moving Averages
| Ichimoku Base | 1,169.15 | Above Base |
| VWMA (20) | 1,184.99 | Below VWMA |
| HMA (9) | 1,164.21 | Above HMA |
Dr. Reddy's Laboratories Technical SWOT Analysis
STRENGTHS
- No notable technical strength signals are currently observed.
WEAKNESSES
- Price is trading below the 200 DMA, indicating relatively weaker long-term structure.
- Price is below the 50 DMA, suggesting weaker medium-term positioning.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- No immediate technical risk signals are identified.
Dr. Reddy's Laboratories Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 1,193.90 | 1,202.05 | 1,160.92 | 1,186.00 |
| Resistance 2 | 1,186.00 | 1,190.08 | 1,158.75 | 1,176.95 |
| Resistance 1 | 1,170.20 | 1,178.35 | 1,156.57 | 1,171.35 |
| Pivot Point | 1,162.30 | 1,166.38 | 1,154.40 | 1,162.30 |
| Support 1 | 1,146.50 | 1,154.65 | 1,152.23 | 1,153.25 |
| Support 2 | 1,138.60 | 1,142.68 | 1,150.06 | 1,147.65 |
| Support 3 | 1,122.80 | 1,130.95 | 1,147.88 | 1,138.60 |
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Dr. Reddy's Laboratories - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 26.64% | 26.63% | 26.64% | 26.64% |
| FII | 32.07% | 33.08% | 33.20% | 35.52% |
| DII (Other) | 18.58% | 17.52% | 16.57% | 14.68% |
| Retail & Others | 9.55% | 9.57% | 9.72% | 9.86% |
| Mutual Funds | 13.16% | 13.19% | 13.87% | 13.31% |
Dr. Reddy's Laboratories - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 35,058.60 +3.9% | 5,392.70 -29.78% | 4,157.60 -27.38% |
| Mar 2025 | 33,741.20 +16.73% | 7,679.50 +6.64% | 5,725.20 +2.64% |
| Mar 2024 | 28,905.40 +12.36% | 7,201.00 +19.05% | 5,577.90 +23.75% |
| Mar 2023 | 25,725.20 | 6,048.50 | 4,507.30 |
Dr. Reddy's Laboratories - Corporate Actions
| Type | Ex-Date | Amount / Ratio | Details |
|---|---|---|---|
| Dividend | 10 Jul 2026 | ₹8 | View Details |
|
Announcement date
12 May 2026
Ex dividend date
10 Jul 2026
Record date
10 Jul 2026
Dividend type
Final
Amount
8.0
Dividend %
800.0
Details
Rs.8.0000 per share(800%)Final Dividend
|
|||
